Filing Details
- Accession Number:
- 0001214659-15-007104
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-10-13 20:02:58
- Reporting Period:
- 2015-10-12
- Filing Date:
- 2015-10-13
- Accepted Time:
- 2015-10-13 20:02:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1316175 | Anthera Pharmaceuticals Inc | ANTH | Pharmaceutical Preparations (2834) | 201852016 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1281719 | Debra Odink | 25801 Industrial Blvd Suite B Hayward CA 94545 | Chief Technology Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-10-12 | 1,205 | $6.15 | 7,896 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 13,855 | Indirect | By Trust |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2015.